| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 3,416 | 3,022 | 3,990 | 2,701 | | Selling General and Administrative | 2,759 | 3,199 | 2,887 | 2,552 | | Non Recurring |
-
| 83 | 868 | (3) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,175) | (6,304) | (7,745) | (5,250) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 80 | 653 | 70 | 2,945 | | Earnings Before Interest And Taxes | (6,095) | (5,651) | (7,675) | (2,305) | | Interest Expense | 12 | 30 | 30 | (1,928) | | Income Before Tax | (6,107) | (5,681) | (7,705) | (377) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,107) | (5,681) | (7,705) | (377) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,107) | (5,681) | (7,705) | (377) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,107) | ($5,681) | ($7,705) | ($377) |
|
0.51% Nasdaq 
Income Statement
